ACIM
MRNA icon

Azimuth Capital Investment Management’s Moderna MRNA Stock Holding History

Azimuth Capital Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,708
Closed -$208K – 301
2023
Q2 		$208K Hold
1,708
– – 0.01% 298
2023
Q1 		$262K Hold
1,708
– – 0.01% 280
2022
Q4 		$307K Hold
1,708
– – 0.02% 278
2022
Q3 		$202K Buy
+1,708
New +$259K 0.01% 296

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Azimuth Capital Investment Management's MRNA Position: Q3 2023 in Review

Azimuth Capital Investment Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,708 shares — an estimated $208K sold.

Azimuth Capital Investment Management first reported a position in MRNA in Q3 2022 and held it in 4 quarters. The position peaked at $307K in Q4 2022. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Azimuth Capital Investment Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Azimuth Capital Investment Management sold 1,708 Moderna shares in Q3 2023, an estimated $208K.
  • Azimuth Capital Investment Management first reported a position in Moderna in Q3 2022 and held it in 4 quarters.
  • Azimuth Capital Investment Management's Moderna position peaked at $307K in Q4 2022.
  • 890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Azimuth Capital Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.